School of Biological, Physical, Mathematics and Actuarial Sciences, Jaramogi Oginga Odinga University of Science and Technology, P.O Box 210-40601, Bondo, Kenya.
School of Health Sciences, Jaramogi Oginga Odinga University of Science and Technology, P.O Box 210-40601, Bondo, Kenya.
Pan Afr Med J. 2023 Sep 14;46:21. doi: 10.11604/pamj.2023.46.21.39483. eCollection 2023.
as a public health policy, the ongoing global coronavirus disease 2019 vaccination drives require continuous tracking, tracing, and testing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Diagnostic testing is important in virus detection and understanding its spread for timely intervention. This is especially important for low-income settings where the majority of the population remains untested. This is well supported by the fact that of about 9% of the Kenyan population had been tested for the virus.
this was a cross-sectional study conducted at the Kisumu and Siaya Referral Hospitals in Kenya. Here we report on the sensitivity and specificity of the rapid antigen detection test (Ag-RDT) of SARS-CoV-2 compared with the quantitative reverse transcriptase polymerase chain reaction (RT-qPCR) using stool and nasopharyngeal swab samples. Further, the mean Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibody levels among symptomatic and asymptomatic individuals in western Kenya were evaluated.
the sensitivity and specificity of Ag-RDT were 76.3% (95% CI, 59.8-88.6%) and 96.3% (95% CI, 87.3-99.5%) with a negative and positive predictive value of 85% (95% CI, 73.8%-93.0%) and 93% (95% CI, 78.6%-99.2%) respectively. There was substantial agreement of 88% (Kappa value of 0.75, 95% CI, 0.74-0.77) between Ag-RDT and nasopharyngeal swab RT-qPCR, and between stool and nasopharyngeal swab RT-qPCR results (83.7% agreement, Kapa value 0.62, 95% CI 0.45-0.80). The mean IgM and IgG antibody response to SARS-CoV-2 were not different in asymptomatic individuals, 1.11 (95% CI, 0.78-1.44) and 0.88 (95% CI, 0.65-1.11) compared to symptomatic individuals 4.30 (95% CI 3.30-5.31) and 4.16 (95% CI 3.32 -5.00).
the choice of an appropriate SARS-CoV-2 diagnostic, screening, and surveillance test should be guided by the specific study needs and a rational approach for optimal results.
作为一项公共卫生政策,正在进行的全球 2019 年冠状病毒病疫苗接种工作需要持续跟踪、追踪和检测严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)。诊断检测对于病毒检测和了解其传播以进行及时干预非常重要。对于大多数人口尚未接受检测的低收入环境来说,这一点尤为重要。肯尼亚约有 9%的人口接受了病毒检测,这一事实充分证明了这一点。
这是在肯尼亚基苏木和锡亚拉转诊医院进行的一项横断面研究。在这里,我们报告了快速抗原检测(Ag-RDT)与使用粪便和鼻咽拭子样本的定量逆转录酶聚合酶链反应(RT-qPCR)相比,对 SARS-CoV-2 的敏感性和特异性。此外,还评估了西肯尼亚有症状和无症状个体的平均免疫球蛋白 M(IgM)和免疫球蛋白 G(IgG)抗体水平。
Ag-RDT 的敏感性和特异性分别为 76.3%(95%CI,59.8%-88.6%)和 96.3%(95%CI,87.3%-99.5%),阴性和阳性预测值分别为 85%(95%CI,73.8%-93.0%)和 93%(95%CI,78.6%-99.2%)。Ag-RDT 与鼻咽拭子 RT-qPCR 之间以及粪便与鼻咽拭子 RT-qPCR 结果之间存在 88%的高度一致性(Kappa 值为 0.75,95%CI,0.74-0.77)(Kappa 值为 0.62,95%CI,0.45-0.80)。与无症状个体相比,无症状个体 SARS-CoV-2 的平均 IgM 和 IgG 抗体反应无差异,分别为 1.11(95%CI,0.78-1.44)和 0.88(95%CI,0.65-1.11),而有症状个体的反应分别为 4.30(95%CI 3.30-5.31)和 4.16(95%CI 3.32-5.00)。
选择适当的 SARS-CoV-2 诊断、筛查和监测检测方法应根据具体的研究需求和合理的方法,以获得最佳结果。